You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 44, 12 February 2004
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 43, 28 November 2003), as amended, are a true and accurate record of that previous meeting.
CMEC recommends to TGA that, on the basis of the data evaluated, active hexose correlated compound is not suitable for use as an ingredient in listed medicines.
CMEC noted the review of safety of hesperidin conducted by the TGA and recommends that it is suitable for use as an ingredient in listed medicines.
CMEC recommends to TGA that, based on current scientific evidence, ginseng does not require any changes to the way in which it is regulated as an ingredient in listed medicines.
|CMEC 44 Extracted Ratified Minutes (pdf)||105KB|